RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 59 filers reported holding RA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | -100.0% | 4 | -99.9% | 0.00% | – |
| Q4 2019 | $205,000 | +184.7% | 4,377 | +43.4% | 0.00% | – |
| Q3 2019 | $72,000 | -37.4% | 3,052 | -20.4% | 0.00% | – |
| Q2 2019 | $115,000 | +325.9% | 3,832 | +218.0% | 0.00% | – |
| Q1 2019 | $27,000 | +3.8% | 1,205 | -13.6% | 0.00% | – |
| Q4 2018 | $26,000 | +8.3% | 1,395 | +7.1% | 0.00% | – |
| Q3 2018 | $24,000 | +84.6% | 1,302 | +0.5% | 0.00% | – |
| Q2 2018 | $13,000 | +160.0% | 1,296 | +29.6% | 0.00% | – |
| Q1 2018 | $5,000 | – | 1,000 | +4900.0% | 0.00% | – |
| Q4 2017 | $0 | – | 20 | -13.0% | 0.00% | – |
| Q4 2016 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,851,808 | $20,453,000 | 1.57% |
| NEA Management Company, LLC | 5,493,636 | $29,171,000 | 1.30% |
| Foresite Capital Management IV, LLC | 450,000 | $2,390,000 | 0.99% |
| Novo Holdings A/S | 1,465,838 | $7,784,000 | 0.98% |
| Consonance Capital Management LP | 1,454,761 | $7,725,000 | 0.71% |
| VHCP Management II, LLC | 544,612 | $2,892,000 | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 270,000 | $1,434,000 | 0.23% |
| Athanor Capital, LP | 67,150 | $357,000 | 0.16% |
| Rock Springs Capital Management LP | 600,000 | $3,186,000 | 0.14% |
| Eventide Asset Management | 388,000 | $2,060,000 | 0.10% |